Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_provenance.
- NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_assertion description "[The TTP pathway of TNF-alpha and GM-CSF mRNA degradation is a possible novel target for anti-TNF-alpha therapies for rheumatoid arthritis, and also for other conditions proven to respond to anti-TNF-alpha therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_provenance.
- NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_assertion evidence source_evidence_literature NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_provenance.
- NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_assertion SIO_000772 15535838 NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_provenance.
- NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_assertion wasDerivedFrom befree-20150227 NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_provenance.
- NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_assertion wasGeneratedBy ECO_0000203 NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_provenance.
- befree-20150227 importedOn "2015-02-27" NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_provenance.